- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Association of Surgical Delay and Overall Survival in Patients with T2 Renal Masses: Implications for Critical Clinical Decision-Making during the COVID-19 Pandemic.
September 25, 2020
A Systematic Review and Meta-Analysis of the Significance of Body Mass Index on Kidney Cancer Outcomes.
September 24, 2020
Surgical Management and Outcomes of Renal Tumors Arising from Horseshoe Kidneys: Results from an International Multicenter Collaboration.
September 23, 2020
Black race may be associated with worse overall survival in renal cell carcinoma patients.
September 23, 2020
Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma.
September 23, 2020
Immune evasion in renal cell carcinoma: biology, clinical translation, future directions.
September 22, 2020
The Role of Targeted Therapy in the Management of High-Risk Resected Kidney Cancer: What Have We Learned and How Will It Inform Future Adjuvant Trials.
September 21, 2020
Immune Related Adverse Events: Classification and Management Approaches in Advanced Kidney Cancer.
September 21, 2020
Biopsy Cell Cycle Proliferation Score Predicts Adverse Surgical Pathology in Localized Renal Cell Carcinoma.
September 21, 2020
Validation of a Web-Based Planning Tool for Percutaneous Cryoablation of Renal Tumors.
September 18, 2020
The role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes.
September 18, 2020
Contemporary trends in percutaneous renal mass biopsy utilization in the United States.
September 17, 2020
Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort.
September 17, 2020